Jim Simons Lumos Pharma, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 213,814 shares of LUMO stock, worth $923,676. This represents 0.0% of its overall portfolio holdings.

Number of Shares

213,814

Previous 215,814 0.93%

Holding current value

$923,676

Previous $500,000 65.4%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.45 - $4.05 $2,900 - $8,100	-2,000 Reduced 0.93%	213,814 $827,000
Q2 2024 Aug 09, 2024	SELL	$2.19 - $3.04 $4,818 - $6,688	-2,200 Reduced 1.01%	215,814 $500,000
Q1 2024 May 13, 2024	SELL	$2.64 - $3.22 $9,504 - $11,592	-3,600 Reduced 1.62%	218,014 $615,000
Q4 2023 Feb 13, 2024	SELL	$2.81 - $4.27 $14,331 - $21,776	-5,100 Reduced 2.25%	221,614 $705,000
Q3 2023 Nov 14, 2023	SELL	$2.63 - $3.49 $11,690 - $15,513	-4,445 Reduced 1.92%	226,714 $748,000
Q2 2023 Aug 11, 2023	BUY	$3.01 - $4.38 $3,747 - $5,453	1,245 Added 0.54%	231,159 $763,000
Q1 2023 May 12, 2023	SELL	$3.16 - $4.0 $10,112 - $12,800	-3,200 Reduced 1.37%	229,914 $761,000
Q4 2022 Feb 13, 2023	SELL	$3.05 - $9.52 $53,066 - $165,638	-17,399 Reduced 6.95%	233,114 $842,000
Q3 2022 Nov 14, 2022	SELL	$7.35 - $9.05 $144,052 - $177,370	-19,599 Reduced 7.26%	250,513 $2.22 Million
Q2 2022 Aug 12, 2022	SELL	$6.68 - $9.39 $10,688 - $15,024	-1,600 Reduced 0.59%	270,112 $2.08 Million
Q1 2022 May 13, 2022	SELL	$6.58 - $10.09 $35,532 - $54,486	-5,400 Reduced 1.95%	271,712 $2.55 Million
Q4 2021 Feb 11, 2022	SELL	$6.84 - $10.04 $63,612 - $93,371	-9,300 Reduced 3.25%	277,112 $1.92 Million
Q3 2021 Nov 12, 2021	SELL	$7.36 - $11.36 $142,379 - $219,759	-19,345 Reduced 6.33%	286,412 $2.72 Million
Q2 2021 Aug 13, 2021	SELL	$9.75 - $13.44 $259,954 - $358,337	-26,662 Reduced 8.02%	305,757 $3.06 Million
Q1 2021 May 13, 2021	BUY	$11.58 - $31.11 $273,369 - $734,413	23,607 Added 7.64%	332,419 $3.89 Million
Q4 2020 Feb 10, 2021	BUY	$13.61 - $35.91 $36,747 - $96,956	2,700 Added 0.88%	308,812 $11 Million
Q3 2020 Nov 13, 2020	SELL	$13.25 - $16.5 $40,796 - $50,803	-3,079 Reduced 1.0%	306,112 $4.23 Million
Q2 2020 Aug 13, 2020	SELL	$7.76 - $16.99 $30,264 - $66,261	-3,900 Reduced 1.25%	309,191 $5.1 Million
Q1 2020 May 14, 2020	BUY	$0.89 - $8.85 $278,650 - $2.77 Million	313,091 New	313,091 $2.66 Million

Others Institutions Holding LUMO

# of Institutions

Shares Held

2.2M

Call Options Held

Put Options Held

View Full List

About LUMOS PHARMA, INC.

Ticker LUMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,396,070
Market Cap $36.3M
Description
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...

More about LUMO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account